Emmerich Ilka Ute
Institut für Pharmakologie, Pharmazie und Toxikologie, Veterinärmedizinische Fakultät der Universität Leipzig.
Tierarztl Prax Ausg K Kleintiere Heimtiere. 2021 Apr;49(2):129-133. doi: 10.1055/a-1428-7648. Epub 2021 Apr 26.
In 2020, one novel pharmaceutical agent for small animals, the ACTH analog tetracosactide for the assessment of adrenocortical function in dogs, were released on the German market. Two established veterinary active pharmaceutical ingredients became available for additional species: The dissociative anesthetic ketamine is now also authorized for hamsters, mice, and rats; and the osmotic laxative lactulose is approved for use also in dogs and cats. Additionally, 3 veterinary drugs with a new combination of active ingredients (mometasone + terbinafine + florfenicol, sarolaner + moxidectin + pyrantel), an agent (tetracaine) in a novel pharmaceutical formulation, one drug (lidocaine) with a new route of administration as well as a crystalloid balanced whole electrolyte solution with a potential base excess (BEpot) of 0 mmol/l were launched on the market for small animals.
2020年，一种用于小动物的新型药物——用于评估犬肾上腺皮质功能的促肾上腺皮质激素类似物替可克肽在德国市场上市。两种已有的兽用活性药物成分可供更多物种使用：解离麻醉剂氯胺酮现在也被批准用于仓鼠、小鼠和大鼠；渗透性泻药乳果糖也被批准用于犬和猫。此外，三种具有新活性成分组合的兽药（莫米松+特比萘芬+氟苯尼考、沙罗拉纳+莫昔克丁+噻嘧啶）、一种新型药物制剂中的药物（丁卡因）、一种具有新给药途径的药物（利多卡因）以及一种潜在碱剩余（BEpot）为0 mmol/l的晶体平衡全电解质溶液在小动物市场上市。
